Q4 2019 Holdings
Filed 2020-05-18 | 64 holdings | $47.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $14.4M | 336,000 | 30.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $13.6M | 45,700 | 28.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.8M | 104,284 | 18.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.0M | 43,300 | 10.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.3M | 14,000 | 4.8% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $1.9M | 13,800 | 4.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.7M | 36,500 | 3.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $20.4K | 93,422 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $19.1K | 293,284 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $15.9K | 66,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $14.3K | 133,300 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $14.1K | 390,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $10.8K | 28,830 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $10.3K | 965,245 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $9.3K | 86,141 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $8.3K | 25,100 | 0.0% |
| Amarin Corp Plc | SPONS ADR NEW | 023111206 | $8.3K | 388,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $7.5K | 83,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $7.3K | 64,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.6K | 64,000 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $5.5K | 114,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $5.5K | 307,633 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $5.2K | 40,100 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.9K | 277,433 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.6K | 35,900 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.2K | 53,781 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $3.0K | 140,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $3.0K | 57,000 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $3.0K | 35,500 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $3.0K | 41,400 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $2.5K | 303,000 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $2.2K | 42,700 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $2.2K | 30,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.2K | 35,000 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $1.8K | 23,100 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.8K | 103,534 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $1.8K | 30,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $1.6K | 80,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.5K | 139,331 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $1.5K | 17,000 | 0.0% |
| Globus Med Inc(GMED) | COM | 379577208 | $1.4K | 24,200 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $1.4K | 37,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.4K | 17,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.3K | 22,000 | 0.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $1.2K | 177,825 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $1.1K | 10,200 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $1.1K | 17,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $989 | 10,700 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $967 | 13,500 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $920 | 94,600 | 0.0% |